Lung Myofibroblasts Are Characterized by Down-Regulated Cyclooxygenase-2 and Its Main Metabolite, Prostaglandin E2

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Gabasa, Marta ^a,b   Royo, Dolores ^a,b   Molina Molina, Maria ^b,c   Roca Ferrer, Jordi ^a,b   Pujols, Laura ^a,b   Picado, Cesar ^b,d   Xaubet, Antoni ^b,d   Pereda, Javier ^a,b,e  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1; ACTA2 PROTEIN, HUMAN; ACTIN; BIOLOGICAL MARKER; PTGS2 PROTEIN, HUMAN;

ARTICLE; CELL COUNT; CELL POPULATION; CELL PROLIFERATION; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST CULTURE; FIBROBLAST MYOFIBROBLAST TRANSITION; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS CELL; LUNG FIBROBLAST; MYOFIBROBLAST; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; SPONTANEOUS PNEUMOTHORAX; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CASE CONTROL STUDY; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ACTINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MYOFIBROBLASTS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84878640280     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065445     Document Type: Article

References (34)

1. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, et al. (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170: 1807-1816.
2. Willis BC, duBois RM, Borok Z, (2006) Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 3: 377-382.
3. Broekelmann TJ, Limper AH, Colby TV, McDonald JA, (1991) Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 88: 6642-6646.
4. Uhal BD, Kim JK, Li X, Molina-Molina M, (2007) Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages. Curr Pharm Des 13: 1247-1256.
5. Brock TG, McNish RW, Peters-Golden M, (1999) Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J Biol Chem 274: 11660-11666.
6. Bonner JC, Rice AB, Ingram JL, Moomaw CR, Nyska A, et al. (2002) Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am J Pathol 161: 459-470.
7. Hodges RJ, Jenkins RG, Wheeler-Jones CP, Copeman DM, Bottoms SE, et al. (2004) Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol 165: 1663-1676.
8. Horowitz JC, Peters-Golden M, (2010) Prostaglandin E2's new trick: "decider" of differential alveolar cell life and death. Am J Respir Crit Care Med 182: 2-3.
9. Elias JA, Rossman MD, Zurier RB, Daniele RP, (1985) Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process. Am Rev Respir Dis 131: 94-99.
10. Saltzman LE, Moss J, Berg RA, Hom B, Crystal RG, (1982) Modulation of collagen production by fibroblasts. Effects of chronic exposure to agonists that increase intracellular cyclic AMP. Biochem J 204: 25-30.
11. Kohyama T, Ertl RF, Valenti V, Spurzem J, Kawamoto M, et al. (2001) Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol 281: L1257-1263.
12. Kolodsick JE, Peters-Golden M, Larios J, Toews GB, Thannickal VJ, et al. (2003) Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol 29: 537-544.
13. Huang SK, White ES, Wettlaufer SH, Grifka H, Hogaboam CM, et al. (2009) Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J 23: 4317-4326.
14. Borok Z, Gillissen A, Buhl R, Hoyt RF, Hubbard RC, et al. (1991) Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis. 144: 1080-1084.
15. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, et al. (1995) Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 95: 1861-1868.
16. Xaubet A, Roca-Ferrer J, Pujols L, Ramirez J, Mullol J, et al. (2004) Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 21: 35-42.
17. Maher TM, Evans IC, Bottoms SE, Mercer PF, Thorley AJ, et al. (2010) Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 73-82.
18. American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664.
19. Roca-Ferrer J, Garcia-Garcia FJ, Pereda J, Perez-Gonzalez M, Pujols L, et al. (2011) Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. J Allergy Clin Immunol 128: 66-72.
20. Ling H, Jia X, Zhang Y, Gapter LA, Lim YS, et al. (2010) Pachymic Acid Inhibits Cell Growth and Modulates Arachidonic Acid Metabolism in Nonsmall Cell Lung Cancer A549 Cells. Mol Carcinog 49: 271-82.
21. Kuhn C, McDonald JA, (1991) The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 138: 1257-1265.
22. Ramos C, Montaño M, García-Alvarez J, Ruiz V, Uhal BD, et al. (2001) Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 24: 591-598.
23. Fang HY, Lin CY, Chow KC, Huang HC, Ko WJ, (2010) Microarray detection of gene overexpression in primary spontaneous pneumothorax. Exp Lung Res 36: 323-330.
24. McAnulty RJ, Chambers RC, Laurent GJ, (1995) Regulation of fibroblast procollagen production. Transforming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein. Biochem J 307: 63-68.
25. Keerthisingam CB, Jenkins RG, Harrison NK, Hernandez-Rodriguez NA, Booth H, et al. (2001) Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 158: 1411-22.
26. Matsumura T, Suzuki T, Aizawa K, Sawaki D, Munemasa Y, et al. (2009) Regulation of transforming growth factor-beta-dependent cyclooxygenase-2 expression in fibroblasts. J Biol Chem 18 284: 35861-71.
27. Diaz A, Chepenik KP, Korn JH, Reginato AM, Jimenez SA, (1998) Differential regulation of cyclooxygenases 1 and 2 by interleukin-1β, tumour necrosis factor-α and transforming growth factor-β1 in human lung fibroblasts. Exp Cell Res 241: 222-229.
28. Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z, (2005) TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res 6: 56.
29. Ramos C, Becerril C, Montano M, Garcia-De-Alba C, Ramirez R, et al. (2010) FGF-1 reverts epithelial-mesenchymal transition induced by TGF-{beta}1 through MAPK/ERK kinase pathway. Am J Physiol Lung Cell Mol Physiol 299: L222-231.
30. Mitchell JA, Belvisi MG, Akarasereenont P, Robbins RA, Kwon OJ, et al. (1994) Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 113: 1008-1014.
31. Anscher MS, (2010) Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist 15: 350-359.
32. Singh SR, Hall IP, (2008) Airway myofibroblasts and their relationship with airway myocytes and fibroblasts. Proc Am Thorac Soc 5: 127-132.
33. Lappi-Blanco E, Kaarteenaho-Wiik R, Maasilta PK, Anttila S, Paakko P, et al. (2006) COX-2 is widely expressed in metaplastic epithelium in pulmonary fibrous disorders. Am J Clin Pathol 126: 717-724.
34. Coward WR, Watts K, Feghali-Bostwick CA, Knox A, Pang L, (2009) Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis. Mol Cell Biol 29: 4325-4339.